(Reuters) – Preliminary data has shown that mRNA COVID-19 vaccines modified to include an Omicron variant strain can increase and extend protection when used as a booster, the European Medicines Agency said on Friday, following a meeting of global health regulators.
(Reporting by Aby Jose Koilparambil in Bengaluru)
